Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03287427
What this trial is testing

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial

Who this might be right for
Colorectal CancerAdenoid Cystic Carcinoma
Peter MacCallum Cancer Centre, Australia 27
Testing effectiveness (Phase 2)Looking for participantsNCT07694986
What this trial is testing

Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD

Who this might be right for
Breast CancerLeptomeningeal Disease
H. Lee Moffitt Cancer Center and Research Institute 30
Large-scale testing (Phase 3)Study completedNCT00432042
What this trial is testing

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Who this might be right for
VaricellaMeaslesMumps+7 more
Merck Sharp & Dohme LLC 955
Testing effectiveness (Phase 2)WithdrawnNCT00771017
What this trial is testing

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT02193061
What this trial is testing

Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs

Who this might be right for
Rotavirus Vaccine
National Institute of Pediatrics, Mexico 1,498
Post-approval studies (Phase 4)Not Yet RecruitingNCT06920069
What this trial is testing

Study of Concomitant Administration of the sIPV and DTaP or MMR

Who this might be right for
PolioDiphteria, Tetanus and PertussisMMR Vaccine
Institute of Medical Biology, Chinese Academy of Medical Sciences 2,640
Testing effectiveness (Phase 2)Study completedNCT01055821
What this trial is testing

Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients

Who this might be right for
Chronic Hepatitis C Infection
Transgene 140
Post-approval studies (Phase 4)Study completedNCT04294433
What this trial is testing

Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children

Who this might be right for
Hepatitis B
Laval University 431
Testing effectiveness (Phase 2)WithdrawnNCT01923233
What this trial is testing

In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Mirror Biologics, Inc.
Large-scale testing (Phase 3)Study completedNCT03143218
What this trial is testing

Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)

Who this might be right for
Malaria,FalciparumChildren, Only
London School of Hygiene and Tropical Medicine 5,920
Testing effectiveness (Phase 2)Active Not RecruitingNCT05419011
What this trial is testing

Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome

Who this might be right for
Colorectal CarcinomaColorectal NeoplasmLynch Syndrome
National Cancer Institute (NCI) 186
Testing effectiveness (Phase 2)Study completedNCT01883609
What this trial is testing

A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 48
Large-scale testing (Phase 3)Study completedNCT00289744
What this trial is testing

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 178
Testing effectiveness (Phase 2)Study completedNCT05596734
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

Who this might be right for
Influenza, HumanCOVID-19
BioNTech SE 1,019
Testing effectiveness (Phase 2)Study completedNCT01570036
What this trial is testing

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Who this might be right for
Breast Cancer
George E. Peoples 275
Testing effectiveness (Phase 2)Study completedNCT00005001
What this trial is testing

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05232851
What this trial is testing

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related CarcinomaLocally Advanced Oropharyngeal Carcinoma+2 more
Mayo Clinic 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205
What this trial is testing

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Who this might be right for
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE 358
Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Large-scale testing (Phase 3)Study completedNCT01553279
What this trial is testing

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 284
Next Page